AstraZeneca has announced an investment of $2.5 billion in Beijing to establish its sixth global strategic R&D centre, together with further research and manufacturing agreements in China.   This investment over the next five years is part of a strategic partnership with the Beijing Municipal Government and the Beijing Economic-Technological Development Area Administrative Office. It includes […]